Standard Biotools (LAB) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 8.66% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 56.76% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 7.74% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | -11.91% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | -3.94% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 179.36% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 16.87% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | -66.31% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | -151.92% |
| 10 | Standard Biotools | 285.26 Mn | -191.45 Mn | 10.54 Mn | 20.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.00% |
| Mar 31, 2026 | 588.10% |
| Dec 31, 2025 | 156.59% |
| Sep 30, 2025 | -28.77% |
| Jun 30, 2025 | 26.81% |
| Mar 31, 2025 | 19.04% |
| Dec 31, 2024 | -810.77% |
| Sep 30, 2024 | -27.99% |
| Jun 30, 2024 | -168.30% |
| Mar 31, 2024 | -90.50% |
| Dec 31, 2023 | 82.05% |
| Sep 30, 2023 | 28.47% |
| Jun 30, 2023 | 73.18% |
| Mar 31, 2023 | 77.87% |
| Sep 30, 2022 | 40.92% |
| Jun 30, 2022 | -76.73% |
| Mar 31, 2022 | -305.82% |
| Sep 30, 2021 | -730.27% |
| Jun 30, 2021 | -176.24% |
| Mar 31, 2021 | -17.74% |